Clinical trial Recruiting at 1 site Observational Ages 18 to 90

Residual and recurrent carotid narrowing after endarterectomy with primary closure

Official title: Residual Stenosis and Restenosis Following Carotid Endarterectomy With Primary Closure, A Prospective Tracking Study

Run by Charles University, Czech Republic · NCT07057297 · Data updated 2026-11-12

The study will test how often and when carotid narrowing comes back after elective carotid endarterectomy with primary closure in adults.

More Carotid Stenosis trials

Quick facts

Study typeObservational
Ages18 Years to 90 Years
SexAll
Enrollment300 (estimated)
SponsorCharles University, Czech Republic
Academic / other
Locations1 site (Prague)
StatusRecruiting
StartedFebruary 1, 2025
Main results expectedJanuary 1, 2026
Study endsJanuary 1, 2027
Registry record updatedJuly 9, 2025
Trial IDNCT07057297 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults meeting guideline indications for elective carotid endarterectomy who can provide informed consent and do not meet exclusion criteria are ideal candidates.

Probably not a fit

Patients who meet exclusion criteria (age ≤18 or ≥90, prior carotid endarterectomy or stent, unsuitable vascular anatomy, high perioperative risk, contralateral cranial nerve X/XII palsy, prior neck irradiation, tandem lesions or intracranial vascular pathology, or lacking consent) are unlikely to gain direct benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective multicenter observational tracking of patients undergoing elective carotid endarterectomy with primary closure at neurosurgical centers in the Czech Republic. Participants undergo preoperative CT angiography and standardized follow-up imaging at 30 days and one year to identify residual stenosis (≥50% within 30 days) and later restenosis. The protocol uses harmonized surgical technique and diagnostic algorithms across sites and collects clinical outcomes such as ischemic stroke, TIA, myocardial infarction, and mortality. Epidemiologic and laboratory risk factors as well as plaque calcification patterns are recorded to characterize predictors of restenosis.

Why it matters

Potential benefit: If successful, the project could give clearer, standardized data on how often narrowing recurs after primary-closure CEA and help refine follow-up and management plans.

How similar studies have gone: Previous observational series have reported variable restenosis rates after CEA, but this coordinated multicenter approach with standardized surgical and imaging protocols is relatively novel in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients without matching any of exclusion criteria who underwent cartotid endarterectomy

Exclusion Criteria:

Age ≤18 or ≥90 years

Previous endarterectomy or stenting

Unsuitable vascular anatomy

High perioperative risk

Contralateral cranial nerve X or XII palsy

History of neck irradiation

Tandem carotid stenosis or intracranial vascular pathology (e.g., aneurysm or AVM)

Absence of signed informed consent

Where it's running

  • Central Military Hospital Prague
    Prague, Czechia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.